Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RE-irradiation of Diffuse MIdline Glioma paTients

NCT06093165 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT06093165
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06093165 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RE-irradiation of Diffuse MIdline Glioma paTients
Lead sponsor
Rigshospitalet, Denmark
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 31, 2023
Completion date
November 30, 2029
Enrollment
59 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, pediatric, diffuse glioma, diffuse intrinsic pontine glioma, diffuse midline glioma, h3 k27m-mutant, pontine tumors, thalamic tumor